Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Combining radiation therapy with surgery and chemotherapy helps patients with rare forms of thyroid cancer live longer

Combining radiation therapy with surgery and chemotherapy helps patients with rare forms of thyroid cancer live longer, according to a study published in the November 15, 2004, issue of the International Journal of Radiation Oncology~Biology~Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.

16 Nov 2004

New software for the investigation of cancer

NorayBio, a bioinformatics company located at the Bizkaia Technological Park (Basque Country) and specialising in developing software for the biosciences, has launched a new software for cancer research on to the market - BITIA, primarily aimed at research centres and cancer wards in hospitals.

16 Nov 2004

Study clarifies BRCA1 and BRCA2 links with other cancers

The largest population study ever done into the risk of cancer in families that fulfil the criteria for BRCA1 and BRCA2 mutation testing has confirmed that breast and ovarian cancers are the major concerns for geneticists and doctors counselling families.

14 Nov 2004

36% of cancer patients ages 65 and older participate in clinical trials

A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study will be published November 15 in the Journal of Clinical Oncology (JCO).

14 Nov 2004

New insight into how our body cells block the development of cancer

Scientists at the Medical Research Council (MRC) Cancer Cell Unit, at the University of Cambridge, have revealed a new insight into how our body cells block the development of cancer.

11 Nov 2004

UT Southwestern Moncrief Cancer Center treats patients with TomoTherapy

UT Southwestern Moncrief Cancer Center this week began treating patients with a TomoTherapy system utilizing image-guided radiation therapy (IGRT). Moncrief is the first cancer center in Texas to offer radiation treatment delivered by the TomoTherapy Hi-Art System.

10 Nov 2004

First ever study of parental role in children's cancer treatment

A team of Detroit-based researchers, led by a behavioral scientist from the Barbara Ann Karmanos Cancer Institute, has launched a unique study to learn how parents can best help their children deal with painful procedures required for cancer treatment.

9 Nov 2004

Researchers have documented a novel form of resistance in leukemia cells to an anti-cancer drug

Researchers at Virginia Commonwealth University’s Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.

8 Nov 2004

The Bush Medicare Prescription has changed the identity of medical oncology

Under previous law, Medicare covered chemotherapy as well as radiation treatment for cancer patients, but did not pay for oral-dose anti-cancer drugs, unless they were available in both oral and injectable form.

4 Nov 2004

European approval for Taxotere (docetaxel) in prostate cancer

Aventis, part of the sanofi-aventis Group announced today that the European Commission has approved Taxotere (docetaxel) Injection Concentrate for use in combination with prednisone as a treatment for men with androgen-independent (hormone- refractory) metastatic prostate cancer.

4 Nov 2004

Peripheral blood transplants from donors may be more harmful than bone marrow transplants in pediatric leukemia patients

A new study has shown for the first time that transplantation of peripheral blood stem cells (PBSC) from sibling donors may be more harmful than bone marrow in pediatric leukemia patients.

3 Nov 2004

Less risks for patients participating in early phase cancer drug trials

The risk of treatment-related (toxic) death for cancer patients enrolled in phase 1 clinical trials had decreased significantly over the past 12 years (from 1991 to 2002), according to an article in the November 3 issue of JAMA.

3 Nov 2004

Maxim Pharmaceuticals to withdraw NDA for advanced malignant melanoma

Maxim Pharmaceuticals has announced that based upon the negative outcome of it's confirmatory Phase 3 clinical trial (M0104) studying Ceplene(TM) (histamine dihydrochloride) in combination with Interleukin-2 (IL-2) in advanced malignant melanoma patients with liver metastases, it plans to close the treatment protocol approved by the FDA earlier this year.

2 Nov 2004

Marie Curie Cancer Care and Cancer Research Technology extend relationship for cancer patient benefit

Cancer Research Technology Limited (CRT), the specialist oncology focussed technology transfer and development company, today announced the completion of a Technology Transfer Agreement with Marie Curie Cancer Care, one of the largest cancer charities in the UK.

2 Nov 2004

Gene silencing may provide hope for leukemia sufferers

Ever since the approval of Gleevec in 2001, a cancer-cell-specific drug used to treat chronic myelogenous leukemia (CML), the field of cancer therapeutics has been rushing full speed into the era of so-called "targeted" medicines.

1 Nov 2004

Researchers are one step closer to understanding how blood cells develop through the use of human embryonic stem cells

This process is also significant because the blood cells were developed without the use of animal serum, which was previously thought to be essential for blood cell development. Instead, specific growth factors are added to guide the cell differentiation.

1 Nov 2004

Oncology News and Research

Further Reading

Combining radiation therapy with surgery and chemotherapy helps patients with rare forms of thyroid cancer live longer

New software for the investigation of cancer

Study clarifies BRCA1 and BRCA2 links with other cancers

36% of cancer patients ages 65 and older participate in clinical trials

New insight into how our body cells block the development of cancer

UT Southwestern Moncrief Cancer Center treats patients with TomoTherapy

First ever study of parental role in children's cancer treatment

Researchers have documented a novel form of resistance in leukemia cells to an anti-cancer drug

The Bush Medicare Prescription has changed the identity of medical oncology

European approval for Taxotere (docetaxel) in prostate cancer

Peripheral blood transplants from donors may be more harmful than bone marrow transplants in pediatric leukemia patients

Less risks for patients participating in early phase cancer drug trials

Maxim Pharmaceuticals to withdraw NDA for advanced malignant melanoma

Marie Curie Cancer Care and Cancer Research Technology extend relationship for cancer patient benefit

Gene silencing may provide hope for leukemia sufferers

Researchers are one step closer to understanding how blood cells develop through the use of human embryonic stem cells

New insight into the role of the breast cancer gene known as BRCA2

Call for MEP's to improve childhood cancer treatment

Micro-array technology is revolutionising current drug development

Higher radiation doses helps patients with advanced non-small cell lung cancer live longer

Cancer Research eBook

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Natural products: the next frontier in drug discovery

Latest News